Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
boston blog main
boston top stories
boston
clinical trials
fda
national top stories
deals
investing
startups
biotech ipos
europe blog main
europe top stories
financing
funding
medical device
san francisco blog main
san francisco top stories
ulcerative colitis
venture capital
20/20 healthcare partners
480 biomedical
acute myeloid leukemia
ally bridge group
alx oncology
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
arsenal medical
arvelle
autoimmune diseases
berkeley lights
big data analytics
biofourmis
biovotion
blackrock
bms
bob langer
What
raised
7
×
ipo
million
new
biotech
company
raises
therapeutics
companies
develop
developing
diseases
drug
genetic
life
medicines
treat
amsterdam
analysis
analytics
arrival
associated
bio
biofourmis
board
bring
brings
bristol
data
days
debut
device
devices
dialysis
digital
disease
disorders
drugs
dyne
dyne’s
Language
unset
7
×
Current search:
xconomy.com
×
raised
×
unset
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device